• LAST PRICE
    0.2945
  • TODAY'S CHANGE (%)
    Trending Up0.0090 (3.1524%)
  • Bid / Lots
    0.2873/ 15
  • Ask / Lots
    0.2989/ 60
  • Open / Previous Close
    0.2700 / 0.2855
  • Day Range
    Low 0.2700
    High 0.2997
  • 52 Week Range
    Low 0.1406
    High 3.5299
  • Volume
    591,598
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.2855
TimeVolumeGLYC
09:32 ET868600.2701
09:33 ET41590.2804
09:35 ET40570.2749
09:37 ET187060.2781
09:39 ET1000.2812
09:42 ET3540.2812
09:44 ET20450.2812
09:46 ET5500.2812
09:48 ET3000.2849
09:53 ET200000.2831
09:55 ET5000.2839
10:00 ET2000.2835
10:02 ET175260.280001
10:04 ET1000.281
10:06 ET14750.2832
10:08 ET3000.2855
10:09 ET148890.2901
10:11 ET46550.2895
10:15 ET5000.2928
10:18 ET190510.2929
10:24 ET2500.2928
10:27 ET113370.2931
10:29 ET9650.2937
10:31 ET3040.293599
10:36 ET1800.290721
10:38 ET175030.29
10:40 ET107940.2934
10:42 ET4000.2876
10:44 ET4820.2876
10:45 ET6500.2876
10:49 ET144900.288
10:51 ET85000.2928
10:58 ET11450.2898
11:02 ET4770.2923
11:07 ET19730.2862
11:20 ET1000.291
11:21 ET46000.292541
11:23 ET1000.2936
11:27 ET104960.2933
11:32 ET1000.2933
11:36 ET137740.291939
11:38 ET32800.2945
11:39 ET13000.29175
11:50 ET5000.2948
11:54 ET1000.2968
11:56 ET14500.2981
11:57 ET36350.29972
12:06 ET10000.2994
12:12 ET2500.295
12:28 ET1000.2959
12:30 ET28000.2947
12:33 ET3000.2912
12:37 ET8000.2933
12:42 ET29230.2934
12:50 ET3660.291
12:53 ET15500.2913
12:55 ET20000.2935
01:02 ET19150.2906
01:04 ET1000.2901
01:06 ET3000.2957
01:09 ET3040.291525
01:11 ET2000.2916
01:13 ET7000.2957
01:15 ET3230.2957
01:20 ET50000.2901
01:24 ET15510.2956
01:26 ET9000.2956
01:31 ET6500.2955
01:45 ET1000.2901
01:51 ET100000.2957
01:58 ET47170.2929
02:00 ET1960.2957
02:03 ET54000.2957
02:07 ET1960.2957
02:14 ET1000.2921
02:20 ET1670.2936
02:23 ET2500.2977
02:39 ET33000.2903
02:50 ET1000.294048
02:59 ET9000.2941
03:01 ET1920.2925
03:03 ET1345440.2912
03:06 ET8650.295199
03:21 ET38000.2865
03:24 ET2000.2932
03:26 ET31000.2906
03:28 ET74010.2908
03:35 ET26000.2886
03:37 ET25000.29
03:42 ET67470.2941
03:44 ET42430.288901
03:46 ET4000.293
03:48 ET2000.293
03:50 ET6000.293
03:51 ET43000.2935
03:55 ET5000.29155
03:57 ET102880.2937
04:00 ET40650.2945
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLYC
GlycoMimetics Inc
19.0M
-0.5x
---
United StatesKAPA
Kairos Pharma Ltd
18.8M
-6.4x
---
United StatesCOCP
Cocrystal Pharma Inc
19.3M
-1.0x
---
United StatesMIRA
Mira Pharmaceuticals Inc
19.7M
-1.6x
---
United StatesGWLL
Goldenwell Biotech Inc
19.8M
-153.8x
---
United StatesMTVA
MetaVia Inc
19.9M
-0.5x
---
As of 2024-12-07

Company Information

GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. It is developing Uproleselan, a specific E-selectin antagonist, to be used in combination with chemotherapy to treat patients with AML, a life-threatening hematologic cancer, and potentially other hematologic cancers. It has designed an antagonist of E-selectin, GMI-1687, that is suitable for subcutaneous administration. GMI-1359 is a drug candidate that simultaneously targets both E-selectin and a chemokine receptor (CXCR4).

Contact Information

Headquarters
9708 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
240-243-1201
Fax
240-243-1018

Executives

Independent Chairman of the Board
Timothy Pearson
President, Chief Executive Officer, Director
Harout Semerjian
Co-Founder, Director
Rachel King
Chief Financial Officer, Senior Vice President
Brian Hahn
Senior Vice President, Chief Commercial Officer
Bruce Johnson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.0M
Revenue (TTM)
$10.0K
Shares Outstanding
64.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.78
EPS
$-0.62
Book Value
$0.60
P/E Ratio
-0.5x
Price/Sales (TTM)
1,899.1
Price/Cash Flow (TTM)
---
Operating Margin
-422,973.50%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.